This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Osiris Therapeutics Inc
OSIR : NASDAQ : Health Care
$13.35 -0.11 | -0.82%
Today's Range: 13.24 - 13.54
Avg. Daily Volume: 152,800
09/22/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
OSIR OSIRIS THERAPEUTICS INC 13.15 451.18 n/m 38.31 165.42
FOLD AMICUS THERAPEUTICS INC 6.70 527.30 n/m 1.29 n/a
AMAG AMAG PHARMACEUTICALS INC 22.76 499.76 n/m 88.96 16.42
ARRY ARRAY BIOPHARMA INC 3.79 499.63 n/m 42.08 -39.53
XOMA XOMA CORP 4.58 489.60 n/m 28.23 -9.66
TKMR TEKMIRA PHARMACEUTICALS CORP 21.00 464.23 n/m 16.81 39.51
SNSS SUNESIS PHARMACEUTICALS INC 7.40 447.28 n/m 7.96 27.75
TGTX TG THERAPEUTICS INC 11.56 440.68 n/m 0.15 60.00
VNDA VANDA PHARMACEUTICALS INC 12.40 420.09 n/m 37.50 15.03
CTIC CTI BIOPHARMA CORP 2.66 398.82 n/m 36.00 2413.96
PGNX PROGENICS PHARMACEUTICAL INC 5.22 363.08 n/m 7.13 -49.20
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OSIR Ind Avg S&P 500
n/m 82.53 19.94

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs